title: How to manage pasireotide, when using as medical treatment for Cushing's disease.
authors.affiliation: ENDOC Center for Endocrine Tumors, Altonaer Str. 59, 20357, Hamburg, Germany. stephan.petersenn@endoc-med.de.|University of Duisburg-Essen, Essen, Germany. stephan.petersenn@endoc-med.de.
authors.forename: Stephan
authors.initials: S
authors.lastname: Petersenn
mesh_terms: D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced*; D047748:Pituitary ACTH Hypersecretion / Q000188:drug therapy*; D013004:Somatostatin / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D013004:Somatostatin; C517782:pasireotide